Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
Terms of Use
Privacy Policy
Home Delivery
Submission Forms
Place an Ad
Local Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rocket Pharmaceuticals Inc
(NQ:
RCKT
)
21.22
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
21.22
Bid (Size)
19.50 (3)
Ask (Size)
25.00 (2)
Prev. Close
21.22
Today's Range
21.22 - 21.22
52wk Range
7.565 - 23.48
Shares Outstanding
65,837,894
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
The Latest Analyst Ratings for Rocket Pharmaceuticals
January 23, 2023
Via
Benzinga
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.
Via
MarketBeat
Performance
YTD
+10.75%
+10.75%
1 Month
+10.75%
+10.75%
3 Month
+13.72%
+13.72%
6 Month
+54.44%
+54.44%
1 Year
+27.52%
+27.52%
More News
Read More
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon Disease
January 09, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Where Rocket Pharmaceuticals Stands With Analysts
December 06, 2022
Via
Benzinga
Expert Ratings for Rocket Pharmaceuticals
December 06, 2022
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Rocket Pharmaceuticals: Here's What You Need To Know
December 06, 2022
Via
Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Via
Benzinga
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
December 23, 2022
Via
Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
December 22, 2022
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Via
Benzinga
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
December 22, 2022
Via
Benzinga
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
December 22, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Pyruvate Kinase Deficiency and Severe Leukocyte Adhesion Deficiency-I Programs at the 64th American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Completes Acquisition of Renovacor
December 01, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
Via
Benzinga
Why DraftKings Shares Are Trading Lower By 5%; Here Are 24 Stocks Moving Premarket
November 28, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 28, 2022
Via
InvestorPlace
Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
Via
Benzinga
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk'
November 15, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Via
Benzinga
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Announces Presentations Highlighting AAV and Lentiviral Gene Therapies at Upcoming Scientific Congresses
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.